Xebio Holdings Co., Ltd. (8281.T) JPX

Currency In JPY

AD

Valuation

Market Cap41.07B
Enterprise Value31.55B
P/E Ratio-20.72
PEG Ratio0.59
Price/Sales Ratio0.18
Price/Book Ratio0.38
Enterprise/Revenue0.14
Enterprise/EBITDA4.44

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue252.33B
Revenue/Share6,094.66
Gross Profit95.09B
EBITDA4.76B
Net Income-2.16B
Diluted EPS-52.27

Balance Sheet

Total Cash15.81B
Total Cash/Share381.82
Total Debt6.29B
Total Debt/Equity0.05
Current Ratio1.83
Book Value Per Share2,857.78

Price History

52-Week Change-4.83
52-Week High1,215
52-Week Low951
Moving Average 50 Days1,037.62
Moving Average 200 Days1,060.82

Statistics

Average Volume116,076
Shares Outstanding41.38M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate35
Trailing Annual Dividend Yield3.23
Payout Ratio0
Last Split Factor3:2
Last Split DateMarch 28, 2006
AD